Business Context and Reporting Period
Company: Inmune Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 28, 2021
Reporting Period Referenced: First quarter ended June 30, 2021
This filing announces the scheduling of a conference call to discuss the Company's financial results for the first quarter of 2021 and to provide a corporate update.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notice of an upcoming event to discuss these metrics.
Material Changes
No material financial changes or operational updates are detailed within this specific filing. The document references a press release (Exhibit 99.1) containing the announcement but does not include the financial data itself.
Guidance, Outlook, and Management Commentary
Upcoming Event: The Company will host a conference call on Wednesday, August 4, 2021, at 4:30 PM Eastern Time.
Agenda: Discussion of Q1 2021 results and a corporate update.
Management Commentary: No specific commentary is included in this filing; details are reserved for the upcoming call.
Investor Verification Checklist
- Verify the date and time of the conference call (August 4, 2021, 4:30 PM ET).
- Review the attached press release (Exhibit 99.1) for any preliminary details not included in the 8-K text.
- Monitor the Company's website or investor relations portal for the audio replay and presentation materials following the call.
- Check subsequent filings (e.g., Form 10-Q) for the actual audited or reviewed financial figures for the period ended June 30, 2021.